The use of remdesivir outside of clinical trials during the COVID-19 pandemic

• Main Authors: Vesa Halimi (Author), Armond Daci (Author), Nevenka Ridova (Author), Irina Panovska-Stavridis (Author), Milena Stevanovic (Author), Venko Filipce (Author), Aleksandar Dimovski (Author), Aleksandra Grozdanova (Author)
• Format: Book
• Published: Taylor & Francis Group, 2020-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

With a scientific background from filoviruses, paramyxoviruses, SARS-CoV, and MERS-CoV, remdesivir entered into the COVID-19 battle to become one of the favorable therapeutic candidates with potential antiviral activity in the treatment of this disease. Globally, remdesivir was accessed and investig...